IHC-plus(tm) MAP17 / PDZK1IP1 Antibody (C-Terminus)

LifeSpan BioSciences

IHC-plus(tm) MAP17 / PDZK1IP1 Antibody (C-Terminus)

23

Immunohistochemistry: LS-B269 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B269 was determined to be 1:500.. IHC, IHC-P (1:500), WB (1:1000) Immunohistochemistry: LS-B269 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B269 was determined to be 1:500.

Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

Unconjugated

PDZK1IP1

PDZK1 interacting protein 1

DD96, MAP17, SPAP, PDZK1-interacting protein 1, 17 kDa membrane-associated protein, epithelial protein up-regulated in carcinoma, membrane associated protein 17, membrane-associated protein 17

Rabbit

Human, Mouse, Rat

-20°C or -80°C

41116161